Powered by
ANN ARBOR—The Michigan “angel investor” community released its 2019 annual research report, showing an increase in the number of angel investors and the amount they invested in Michigan startups last …
FERNDALE—Bollinger Motors, the electric truck developer, Thursday announced plans to manufacture and sell an all-electric chassis cab truck called the B2 Chassis Cab. The company says the truck is the …
ANN ARBOR—The Michigan Growth Capital Symposium, the Midwest’s oldest and largest event for young companies seeking capital, will be held online Tuesday, May 5 as the Midwest Venture Showcase 2020. …
ANN ARBOR—BlueWillow Biologics, the Ann Arbor-based clinical-stage biopharmaceutical company developing novel anti-infective products and nasal vaccines, announced the appointment of Chad Costley, MD, as chief medical officer. Costley is a …
ANN ARBOR—Millendo Therapeutics Inc., a biopharmaceutical company primarily focused on developing novel treatments for endocrine diseases, announced today that it is discontinuing the development of livoletide as a potential treatment …
ANN ARBOR—Millendo Therapeutics Inc. (Nasdaq: MLND), a pharmaceutical startup focused on developing novel treatments for orphan endocrine diseases, provided a corporate update and reported financial results for the year ended …
ANN ARBOR—Esperion Therapeutics Inc. (Nasdaq: ESPR) announced U.S. Food and Drug Administration approval of Nexlizet, a combination tablet of Esperion’s new non-statin cholesterol reducing drug bempedoic acid and an earlier …
ANN ARBOR—Esperion Therapeutics Inc. (NASDAQ:ESPR) announced that the U.S. Food and Drug Administration (FDA) approved Nexletol (bempedoic acid) tablet, an oral, once-daily, non-statin cholesterol-lowering medicine. Nexletol is indicated as an …
ANN ARBOR—Millendo Therapeutics Inc. (Nasdaq: MLND), a biopharmaceutical company primarily focused on developing novel treatments for orphan endocrine diseases, announced that Christophe Arbet-Engels has joined the company as Chief Medical …
ANN ARBOR—Esperion Therapeutics Inc. (Nasdaq: ESPR) has announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has issued a “positive opinion” for both its bempedoic …